HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Lipid status in patients on a chronic hemodialysis program].

Abstract
Dyslipidemia causes development of atherosclerosis in chronic hemodialysis patients. The goal of this study was to determine values of serum lipids in hemodialysis patients. The study comprised 45 patients, whereas the control group consisted of 45 healthy persons of corresponding age and sex. We determined triacyglycerols, total cholesterol, HDL (high density lipoprotein) and LDL (low density lipoprotein) cholesterol in the serum of patients on an empty stomach. There were 51% of patients with normal findings, and 49% with hyperlipoproteinemia type IV. In regard to the control group triacyglycerol was increased both in patients with hyperlipoproteinemia type IV and in patients with normolipemia. Levels of total cholesterol were higher in patients with hyperlipoproteinemia type IV, while values of HDL cholesterol were decreased in both subgroups of patients in regard to the control group. Values of total cholesterol in relation to HDL cholesterol > 4.5 occurred in 38% of patients. Lipid profile of hemodialysis patients, including those with normolipidemia, points to high risk of cardiovascular diseases.
AuthorsV Tepsić, V Ristić, G Perunicić, Z Rasić, S Pljesa, L Bokan, N Ranković
JournalMedicinski pregled (Med Pregl) 1997 Jan-Feb Vol. 50 Issue 1-2 Pg. 45-7 ISSN: 0025-8105 [Print] Serbia
Vernacular TitleLipidni status bolesnika na hronicnom programu hemodijalize.
PMID9132551 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Lipids
Topics
  • Adult
  • Aged
  • Arteriosclerosis (blood)
  • Female
  • Humans
  • Kidney Failure, Chronic (complications, therapy)
  • Lipids (blood)
  • Male
  • Middle Aged
  • Renal Dialysis (adverse effects)
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: